Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fengcai Zhu and Hongxing Pan.
Fengcai Zhu
Connection Strength
0.696
Hongxing Pan
  1. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nat Med. 2021 06; 27(6):1062-1070.
    View in: PubMed
    Score: 0.235
  2. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need. Signal Transduct Target Ther. 2021 02 02; 6(1):48.
    View in: PubMed
    Score: 0.232
  3. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 02; 21(2):181-192.
    View in: PubMed
    Score: 0.228
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.